Cargando…
Human papillomavirus DNA in plasma of patients with cervical cancer
BACKGROUND: Human papillomavirus (HPV) is a crucial etiological factor for cervical cancer (CC) development. From a diagnostic view-point, the consistent presence of HPV in CC allows the viral DNA to be used as a genetic marker. The aims of this study were to evaluate the presence, physical status a...
Autores principales: | Pornthanakasem, Wichai, Shotelersuk, Kanjana, Termrungruanglert, Wichai, Voravud, Narin, Niruthisard, Somchai, Mutirangura, Apiwat |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC32170/ https://www.ncbi.nlm.nih.gov/pubmed/11244579 http://dx.doi.org/10.1186/1471-2407-1-2 |
Ejemplares similares
-
Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
por: Kitkumthorn, Nakarin, et al.
Publicado: (2006) -
Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer
por: Hirunsatit, Rungnapa, et al.
Publicado: (2003) -
Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.
por: Mutirangura, A., et al.
Publicado: (1998) -
Replication independent DNA double-strand break retention may prevent genomic instability
por: Kongruttanachok, Narisorn, et al.
Publicado: (2010) -
Value of CCNA1 Promoter Methylation in Triaging ASC-US Cytology
por: Oranratanaphan, Shina, et al.
Publicado: (2020)